Clinical Trial Update: A Real-world, Multi-center, Prospective, Observational Study for PNH in China

View source ↗

Summary

A real-world, multi-center, prospective observational study on paroxysmal nocturnal hemoglobinuria (PNH) conducted in China has completed, sponsored by AstraZen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Snippet

Sponsor: AstraZeneca | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Status: COMPLETED